^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Syantra DX™ Breast Cancer test

Company:
Syantra
Type:
CE Marked
Evidence

News

11ms
Syantra receives CE Mark approval for their breast cancer test built on the Syantra DX™ liquid biopsy platform (Syantra Press Release)
"Syantra announced...that it has obtained CE marking for the Syantra DX™ Breast Cancer test. Syantra DX™ Breast Cancer is a minimally invasive blood test for the detection of an active breast cancer signature - in the earliest stages when it is easier to treat."
European regulatory
|
Syantra DX™ Breast Cancer test